• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

immuno-oncology

AZ
Pharma

AZ's Imfinzi keeps MIBC race against Keytruda hot with FDA nod

AstraZeneca has crossed the finish line in MIBC with its own doublet wedding Pfizer and Astellas’ Padcev with its PD-L1 inhibitor Imfinzi.
Fraiser Kansteiner Nov 13, 2026 5:40pm
GSK

GSK's Jemperli snags FDA nod in rectal cancer after data buzz

Oct 19, 2026 1:24pm
FDA stop sign

FDA rejects Hengrui, Elevar PD-1 liver cancer combo a 3rd time

Jul 10, 2026 10:55am
BioNTech

BioNTech lays commercial groundwork for PD-L1xVEGF via HER2 ADC

Jul 9, 2026 2:17pm
Person throwing piece of paper into full waste bin

Nature retracts provocative PD-1 time-of-day study

Jun 24, 2026 11:00am
AZ

Another AstraZeneca Emerald glimmers in liver cancer

Apr 2, 2026 10:12am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings